Recently Viewed
empty-cart

There are no Recent Items

Close
Login/Register

Close
Single User License Price USD 4450
Single User License Price INR 307807
Corporate User License Price USD 6250
Corporate User License Price INR 432313
Request a Quote

Report Title

Global Radiopharmaceutical Market Research Report - Forecast to 2023

Quote Request for License Type
License Type Price  
Single User License USD 4450
Enterprise Wide License USD 6250
"Thanks for submitting the form. Our marketing team will connect back to you for the budget constraint."
Close
REQUEST A CUSTOMIZED RESEARCH

Report Title

Global Radiopharmaceutical Market Research Report - Forecast to 2023


Quote Request for License Type
License Type Price  
Single User License USD 4450
"Thanks for letting us know your requirement. Our research team will connect back to you for the bespoke requirement."
Close
REQUEST FOR SAMPLE REPORT

Report Title

Global Radiopharmaceutical Market Research Report - Forecast to 2023

"Thanks for submitting the form. The concerned team will send the sample report in the next 12 hours."
"Thank you for downloading the sample report."
Close

Global Radiopharmaceutical Market Research Report - Forecast to 2023



Executive Summary

Introduction

Radiopharmaceuticals are those radioisotopes when used for diagnosis or therapy, typically stimulate no physiological response from the patient. They are the unique medicinal formulations containing radioisotopes which can be used diagnosis and treatment of various chronic diseases. Radioisotopes play a very crucial part in the medical diagnostic procedures. In combination with imaging devices which record the gamma rays emitted from inside, healthcare professionals can study the dynamic processes taking place in various parts of the body.

Increasing prevalence of chronic diseases which indicates the growing need for early diagnosis and treatment is one of the major factors responsible for the growth of the market. Moreover, rising expenditure in oncology and growing emphasis on cancer management has also accelerated the market growth owing to the need for new diagnostic and treatment options for common as well as rare cancers.

 

 

Both diagnostic & treatment characteristics of radiopharmaceutical driving the market growth. As per World Nuclear Association, in a quarter of the world population, about one person in 50 uses diagnostic nuclear medicine each year, and the frequency of therapy with radioisotopes is about one-tenth of this. Nuclear medicine uses radiation to provide diagnostic information about the functioning of a person's specific organs and used to treat some medical conditions, especially cancer, using radiation to weaken or destroy particular targeted cells.

 

Increasing Prevalence of Chronic Diseases is also driving the growth of the market. According to the World Cancer Research Fund International, in 2015, cancer was responsible for 8.8 million deaths and is the second leading cause of death across the globe. As per the American Heart Association, in 2017, about 92.1 million Americans were diagnosed with cardiovascular disease.Additionally, as per the National Research University Higher School of Economics, tension-type headaches (about 1,500 million cases), migraine (about 1,000 million), medication overuse headaches (about 60 million), and Alzheimer's disease and other dementias (about 46 million cases) are the most common type of neurological disorders in 2015.

Whereas certain factors such as the high cost of radiopharmaceuticals is restraining the growth of the market. As per National Research Universal (NRU), the cost of some nuclear medicine have increased by as much as 1,000 percent recently. Similarly, according to the research, the overall financial cost for the underutilized radiopharmaceutical materials due to canceled and rescheduled procedures for 142 patients was about 39,760 US dollar. The daily financial loss from these cancellations was between USD 560 to USD 1120

 

The global radiopharmaceuticals market is expected to reach to the market value of USD 10,473.88 million by 2023 from USD 5,841.22 million in 2016 and have a CAGR of 8.7% during the forecast period, 2017-2023.

 

On the basis of type, the market for Radiopharmaceutical is segmented into diagnostic type radiopharmaceuticals and therapeutic type radiopharmaceuticals By type, the market for diagnostic type radiopharmaceuticals accounted for the largest market share in 2017.

On the basis of type of tests, the market for Radiopharmaceutical is segmented into myocardial perfusion scan, lung scan, bone scan, white blood cell scan, gallium scan, renal nuclear medicine scan, parathyroid scans, hepatobiliary scans, cerebral perfusion scan and others. By type of tests, the market for intermediate Radiopharmaceutical accounted for the largest market share in 2017.

The global Radiopharmaceutical, by application, is segmented into oncology, cardiology, neurology, urology, and others. By application, the market for Oncology accounted for the largest market share in 2017.

The global Radiopharmaceutical, by route of administration, is segmented into oral, intravenous and other route of administration. The intravenous segment holds the largest market share in global Radiopharmaceutical, by route of administration.

On the basis of the route of administration, the global Radiopharmaceutical market is segmented into intravenous, intravitreal, and others. The intravitreal segment dominates the global Radiopharmaceutical market.

The global Radiopharmaceutical, on the basis of end-user, is segmented into hospitals, diagnostic centers, research institutes and others. Hospitals hold the largest market share in the global Radiopharmaceutical market.

Key Players

The key players for the Radiopharmaceutical market are Bayer AG, Cardinal Health Inc., General Electric Company, Lantheus Medical Imaging, Inc., Siemens, Avid Radiopharmaceuticals, IBA Dosimetry and Others.

Study Objectives

To provide historical and forecast revenue of the market segments and sub-segments with respect to - regional markets and their countries

To provide insights into factors influencing and affecting the market growth

To provide strategic profiling of key players in the market, comprehensively analyzing their market share, core competencies, and drawing a competitive landscape for the market

To provide economic factors that influence the global Radiopharmaceutical market

 

 

Target Audience

Pharmaceutical and Medical Device Industries

Potential Investors

Medical Research Institutes

Key Executive (CEO and COO) and Strategy Growth Manager

Research Companies

Key Findings

The major market players in the global Radiopharmaceutical market are F Bayer AG, Cardinal Health Inc., General Electric Company, Lantheus Medical Imaging, Inc., Siemens, Avid Radiopharmaceuticals, IBA Dosimetry and Others.

Siemens accounted for more than 13.2% share of the global Radiopharmaceutical Market

Based on type of tests, Bone Scan segment accounts the largest market share which is expected to reach USD 2,513.68 million by 2023 from USD 1,470.34 million in 2016

Based on application, the market for oncology is expected to reach USD 4,747.76 million by 2023

Based on route of administration, intravenous segment was the largest segment in the year 2017 and is expected to reach USD 7,316.86 million by 2023 from USD 3,995.90 million in 2016

On the basis of region, Asia pacific region is projected to be the fastest growing region, at a CAGR of 9.3% during the forecast period.

 

 

The report also covers regional analysis

Americas

North America

o U.S.

o Canada

South America

Europe

Western Europe

o Germany

o France

o Italy

o U.K.

o Spain

o Rest of Western Europe

Eastern Europe

Asia Pacific

o China

o Japan

o India

o Australia

o Republic of Korea

o Rest of Asia Pacific

The Middle East & Africa

Middle East

Africa

Table of Contents

1 Report Prologue

2 Executive Summary

3 Market Introduction

3.1 Scope of Study

3.2 Research Objective

3.3 Assumptions & Limitations

3.3.1 Assumptions

3.3.2 Limitations

3.4 Market Structure

4 Research Methodology

4.1 Primary Research

4.2 Secondary Research

4.3 Market Size Estimation

4.4 Forecast Model

5 Market Dynamics

5.1 Introduction

5.2 Drivers

5.2.1 All-rounder (Both diagnostic & treatment), characteristics of radiopharmaceutical driving

the market growth (35%)

5.2.2 Increasing Prevalence of Chronic Diseases (20%)

5.2.3 Increasing Expenditure on Oncology Medicine (25%)

5.2.4 Increasing use of radiopharmaceuticals for the diagnosis & treatment of chronic diseases in

the elderly population (20%)

5.3 Restraints

5.3.1 The high cost of radiopharmaceuticals (55%)

5.3.2 Side Effects of Radiation Exposure (45%)

5.4 Opportunity

5.4.1 Potential radioisotopes in the pipeline

6 Market Factor Analysis

6.1 Porter's Five Forces Model

6.1.1 Bargaining Power of Suppliers

6.1.2 Bargaining Power of Buyers

6.1.3 Threat of New Entrants

6.1.4 Threat of Substitutes

6.1.5 Intensity of Rivalry

6.2 Value Chain Analysis

6.2.1 Research & Product Development

6.2.2 Manufacturing

6.2.3 Distribution & Sales

6.2.4 Post-Sales Monitoring

6.3 Procedure Numbers

7 Global Radiopharmaceutical Market, by Type

7.1 Introduction

7.1.1 Diagnostic Type

7.1.2 Therapeutic Type

8 Global Radiopharmaceuticals Market, by Type of Test

8.1 Introduction

8.1.1 Bone Scan

8.1.2 Myocardial Perfusion Scan

8.1.3 Parathyroid Scan

8.1.4 Renal Nuclear Medicine Scan

8.1.5 Lung Scan

8.1.6 Gallium Scan

8.1.7 White Blood Cell Scan

8.1.8 Hepatobiliary Scan

8.1.9 Cerebral Perfusion Scan

9 Global Radiopharmaceutical Market, by Application

9.1 Introduction

9.1.1 Oncology

9.1.2 Cardiology

9.1.3 Neurology

9.1.4 Urology

10 Global Radiopharmaceutical Market, by Route of Administration

10.1 Introduction

10.1.1 Oral

10.1.2 Intravenous

11 Global Radiopharmaceutical Market, by End-User

11.1 Introduction

11.1.1 Hospitals

11.1.2 Diagnostic Centers

11.1.3 Research Institutes

12 Global Radiopharmaceutical Market, by Region

12.1 Introduction

12.2 Americas

12.2.1 North America

12.2.1.1 U.S.

12.2.1.2 Canada

12.2.2 South America

12.3 Europe

12.3.1 Western Europe

12.3.1.1 Germany

12.3.1.2 France

12.3.1.3 U.K.

12.3.1.4 Italy

12.3.1.5 Spain

12.3.1.6 Rest of Western Europe

12.3.2 Eastern Europe

12.4 Asia Pacific

12.4.1 Japan

12.4.2 China

12.4.3 India

12.4.4 Australia

12.4.5 Republic of Korea

12.4.6 Rest of Asia Pacific

12.5 The Middle East & Africa

12.5.1.1 Middle East

12.5.1.2 Africa

13 Competitive Landscape

13.1 Company Market Share Analysis

13.1.1 Introduction

13.1.2 Company Share Analysis

13.2 Recent Developments, 2013-2018

14 Company Profile

14.1 Jubilant Life Sciences Ltd.

14.1.1 Company Overview

14.1.2 Financial Overview

14.1.3 Products Offerings

14.1.4 Key Developments

14.1.5 SWOT Analysis

14.1.6 Key Strategy

14.2 Siemens AG

14.2.1 Company Overview

14.2.2 Financial Overview

14.2.3 Products Offerings

14.2.4 Key Developments

14.2.5 SWOT Analysis

14.2.6 Key Strategy

14.3 Sun Pharmaceutical Industries Ltd.

14.3.1 Company Overview

14.3.2 Financial Overview

14.3.3 Products Offerings

14.3.4 Key Developments

14.3.5 SWOT Analysis

14.3.6 Key Strategy

14.4 Bayer AG

14.4.1 Company Overview

14.4.2 Financial Overview

14.4.3 Products Offerings

14.4.4 Key Developments

14.4.5 SWOT Analysis

14.4.6 Key Strategy

14.5 Cardinal Health Inc.

14.5.1 Company Overview

14.5.2 Financial Overview

14.5.3 Products Offerings

14.5.4 Key Developments

14.5.5 SWOT Analysis

14.5.6 Key Strategy

14.6 Medtronic

14.6.1 Company Overview

14.6.2 Financial Overview

14.6.3 Products Offerings

14.6.4 Key Developments

14.6.5 SWOT Analysis

14.6.6 Key Strategy

14.7 General Electric Company (GE Healthcare)

14.7.1 Company Overview

14.7.2 Financial Overview

14.7.3 Products Offerings

14.7.4 Key Developments

14.7.5 SWOT Analysis

14.7.6 Key Strategy

14.8 Lantheus Medical Imaging, Inc.

14.8.1 Company Overview

14.8.2 Financial Overview

14.8.3 Products Offerings

14.8.4 Key Developments

14.8.5 SWOT Analysis

14.8.6 Key Strategy

14.9 Advanced Accelerator Applications S.A.

14.9.1 Company Overview

14.9.2 Financial Overview

14.9.3 Products Offerings

14.9.4 Key Developments

14.9.5 SWOT Analysis

14.9.6 Key Strategy

14.10 Mallinckrodt Pharmaceuticals

14.10.1 Company Overview

14.10.2 Financial Overview

14.10.3 Products Offerings

14.10.4 Key Developments

14.10.5 SWOT Analysis

14.10.6 Key Strategy

14.11 Nordion, Inc.

14.11.1 Company Overview

14.11.2 Financial Overview

14.11.3 Products Offerings

14.11.4 Key Developments

14.11.5 SWOT Analysis

14.11.6 Key Strategy

14.12 Canadian Nuclear Laboratories (CNL)

14.12.1 Company Overview

14.12.2 Financial Overview

14.12.3 Products Offerings

14.12.4 Key Developments

14.12.5 SWOT Analysis

14.12.6 Key Strategy

14.13 Bracco Diagnostic Inc.

14.13.1 Company Overview

14.13.2 Financial Overview

14.13.3 Products Offerings

14.13.4 Key Developments

14.13.5 SWOT Analysis

14.13.6 Key Strategy

14.14 IBA Dosimetry GmbH

14.14.1 Company Overview

14.14.2 Financial Overview

14.14.3 Products Offerings

14.14.4 Key Developments

14.14.5 SWOT Analysis

14.14.6 Key Strategy

14.15 Avid Radiopharmaceuticals

14.15.1 Company Overview

14.15.2 Financial Overview

14.15.3 Products Offerings

14.15.4 Key Developments

14.15.5 SWOT Analysis

14.15.6 Key Strategy

15 Appendix

15.1 Discussion Blue Print

To know more information on Purchase by Section, please send a mail to sales@kenresearch.com

List of Figures

FIGURE 1 GLOBAL RADIOPHARMACEUTICAL MARKET: MARKET STRUCTURE

FIGURE 2 TOP-DOWN & BOTTOM-UP APPROACH

FIGURE 3 DRIVERS & RESTRAINTS: GLOBAL RADIOPHARMACEUTICAL MARKET

FIGURE 4 PORTERS FIVE FORCES MODEL

FIGURE 5 VALUE CHAIN: RADIOPHARMACEUTICAL MARKET

FIGURE 6 DIAGNOSIS PROCEDURE NUMBERS, 2014-20232014-2023 E (UNITS)

FIGURE 7 THERAPEUTIC PROCEDURE NUMBERS, 2014-20232014-2023 E (UNITS)

FIGURE 8 GLOBAL RADIOPHARMACEUTICAL MARKET, BY TYPE, 2016 & 2023 (USD MILLION)

FIGURE 9 GLOBAL RADIOPHARMACEUTICAL MARKET, BY TYPE OF TEST, 2016 & 2023 (USD MILLION)

FIGURE 10 GLOBAL RADIOPHARMACEUTICAL MARKET, BY APPLICATION, 2016 & 2023 (USD MILLION)

FIGURE 11 GLOBAL RADIOPHARMACEUTICAL MARKET, BY ROUTE OF ADMINISTRATION, 2016 & 2023 (USD MILLION)

FIGURE 12 GLOBAL RADIOPHARMACEUTICAL MARKET, BY END-USER, 2016 & 2023 (USD MILLION)

FIGURE 13 GLOBAL RADIOPHARMACEUTICAL MARKET, BY REGION, 2016 & 2023 (USD MILLION)

FIGURE 14 AMERICAS RADIOPHARMACEUTICAL MARKET, BY REGION, 2016 (%)

FIGURE 15 EUROPE RADIOPHARMACEUTICAL MARKET, BY COUNTRY, 2016 (%)

FIGURE 16 ASIA PACIFIC RADIOPHARMACEUTICAL MARKET, BY COUNTRY, 2016 (%)

FIGURE 17 MIDDLE EAST & AFRICA RADIOPHARMACEUTICAL MARKET, BY COUNTRY, 2016 (%)

FIGURE 18 GLOBAL RADIOPHARMACEUTICALS MARKET, COMPANY SHARE ANALYSIS 2016 (%)

FIGURE 19 GLOBAL RADIOPHARMACEUTICALS MARKET COMPETITIVE LANDSCAPE 2016 (%)

List of Tables

 

TABLE 1 MARKET SYNOPSIS

TABLE 2 GLOBAL RADIOPHARMACEUTICAL MARKET, BY TYPE, 2014-2023 (USD MILLION)

TABLE 3 GLOBAL RADIOPHARMACEUTICAL MARKET FOR DIAGNOSTIC, BY TYPE, 2014-2023 (USD MILLION)

TABLE 4 GLOBAL RADIOPHARMACEUTICAL MARKET FOR SPECT RADIOPHARMACEUTICALS, BY TYPE, 2014-2023 (USD MILLION)

TABLE 5 GLOBAL RADIOPHARMACEUTICAL MARKET FOR PET RADIOPHARMACEUTICALS, BY TYPE, 2014-2023 (USD MILLION)

TABLE 6 GLOBAL RADIOPHARMACEUTICAL MARKET FOR THERAPEUTIC, BY TYPE, 2014-2023 (USD MILLION)

TABLE 7 GLOBAL RADIOPHARMACEUTICAL MARKET FOR BETA EMITTERS, BY TYPE, 2014-2023 (USD MILLION)

TABLE 8 GLOBAL RADIOPHARMACEUTICAL MARKET FOR BRACHYTHERAPY, BY TYPE, 2014-2023 (USD MILLION)

TABLE 9 GLOBAL RADIOPHARMACEUTICAL MARKET FOR DIAGNOSTIC TYPE, BY REGION, 2014-2023 (USD MILLION)

TABLE 10 GLOBAL RADIOPHARMACEUTICAL MARKET FOR THERAPEUTIC TYPE, BY REGION, 2014-2023 (USD MILLION)

TABLE 11 GLOBAL RADIOPHARMACEUTICALS MARKET, BY TYPE OF TEST, 2014-2023 (USD MILLION)

TABLE 12 GLOBAL RADIOPHARMACEUTICALS MARKET FOR BONE SCAN, BY TYPE, 2014-2023 (USD MILLION)

TABLE 13 GLOBAL RADIOPHARMACEUTICALS MARKET FOR MYOCARDIAL PERFUSION SCAN, BY TYPE, 2014-2023 (USD MILLION)

TABLE 14 GLOBAL RADIOPHARMACEUTICALS MARKET FOR LUNG SCAN, BY TYPE, 2014-2023 (USD MILLION)

TABLE 15 GLOBAL RADIOPHARMACEUTICALS MARKET FOR WHITE BLOOD CELL SCAN, BY TYPE, 2014-2023 (USD MILLION)

TABLE 16 GLOBAL RADIOPHARMACEUTICALS MARKET FOR BONE SCAN, BY REGION, 2014-2023 (USD MILLION)

TABLE 17 GLOBAL RADIOPHARMACEUTICALS MARKET FOR MYOCARDIAL PERFUSION SCAN, BY REGION, 2014-2023 (USD MILLION)

TABLE 18 GLOBAL RADIOPHARMACEUTICALS MARKET FOR PARATHYROID SCAN, BY REGION, 2014-2023 (USD MILLION)

TABLE 19 GLOBAL RADIOPHARMACEUTICALS MARKET FOR RENAL NUCLEAR MEDICINE SCAN, BY REGION, 2014-2023 (USD MILLION)

TABLE 20 GLOBAL RADIOPHARMACEUTICALS MARKET FOR LUNG SCAN, BY REGION, 2014-2023 (USD MILLION)

TABLE 21 GLOBAL RADIOPHARMACEUTICALS MARKET FOR GALLIUM SCAN, BY REGION, 2014-2023 (USD MILLION)

TABLE 22 GLOBAL RADIOPHARMACEUTICALS MARKET FOR WHITE BLOOD CELL SCAN, BY REGION, 2014-2023 (USD MILLION)

TABLE 23 GLOBAL RADIOPHARMACEUTICALS MARKET FOR HEPATOBILIARY SCAN, BY REGION, 2014-2023 (USD MILLION)

TABLE 24 GLOBAL RADIOPHARMACEUTICALS MARKET FOR CEREBRAL PERFUSION SCAN, BY REGION, 2014-2023 (USD MILLION)

TABLE 25 GLOBAL RADIOPHARMACEUTICAL MARKET, BY APPLICATION, 2014-2023 (USD MILLION)

TABLE 26 GLOBAL RADIOPHARMACEUTICAL MARKET FOR ONCOLOGY, BY TYPE, 2014-2023 (USD MILLION)

TABLE 27 GLOBAL RADIOPHARMACEUTICAL MARKET FOR CARDIOLOGY, BY TYPE, 2014-2023 (USD MILLION)

TABLE 28 GLOBAL RADIOPHARMACEUTICAL MARKET FOR NEUROLOGY, BY TYPE, 2014-2023 (USD MILLION)

TABLE 29 GLOBAL RADIOPHARMACEUTICAL MARKET FOR UROLOGY, BY TYPE, 2014-2023 (USD MILLION)

TABLE 30 GLOBAL RADIOPHARMACEUTICAL MARKET FOR ONCOLOGY, BY REGION, 2014-2023 (USD MILLION)

TABLE 31 GLOBAL RADIOPHARMACEUTICAL MARKET FOR CARDIOLOGY, BY REGION, 2014-2023 (USD MILLION)

TABLE 32 GLOBAL RADIOPHARMACEUTICAL MARKET FOR NEUROLOGY, BY REGION, 2014-2023 (USD MILLION)

TABLE 33 GLOBAL RADIOPHARMACEUTICAL MARKET FOR UROLOGY, BY REGION, 2014-2023 (USD MILLION)

TABLE 34 GLOBAL RADIOPHARMACEUTICAL MARKET, BY ROUTE OF ADMINISTRATION, 2014-2023 (USD MILLION)

TABLE 35 GLOBAL RADIOPHARMACEUTICAL MARKET FOR ORAL, BY REGION, 2014-2023 (USD MILLION)

TABLE 36 GLOBAL RADIOPHARMACEUTICAL MARKET FOR ORAL, BY REGION, 2014-2023 (USD MILLION)

TABLE 37 GLOBAL RADIOPHARMACEUTICAL MARKET, BY END-USER, 2014-2023 (USD MILLION)

TABLE 38 GLOBAL RADIOPHARMACEUTICAL MARKET FOR HOSPITALS, BY REGION, 2014-2023 (USD MILLION)

TABLE 39 GLOBAL RADIOPHARMACEUTICAL MARKET FOR DIAGNOSTIC CENTERS, BY REGION, 2014-2023 (USD MILLION)

TABLE 40 GLOBAL RADIOPHARMACEUTICAL MARKET FOR RESEARCH INSTITUTES, BY REGION, 2014-2023 (USD MILLION)

TABLE 41 GLOBAL RADIOPHARMACEUTICAL MARKET, BY REGION, 2014-2023 (USD MILLION)

TABLE 42 AMERICAS RADIOPHARMACEUTICAL MARKET, BY REGION, 2014-2023 (USD MILLION)

TABLE 43 AMERICAS RADIOPHARMACEUTICAL MARKET, BY TYPE, 2014-2023 (USD MILLION)

TABLE 44 AMERICAS RADIOPHARMACEUTICAL MARKET FOR DIAGNOSTIC, BY TYPE, 2014-2023 (USD MILLION)

TABLE 45 AMERICAS RADIOPHARMACEUTICAL MARKET FOR SPECT RADIOPHARMACEUTICALS, 2014-2023 (USD MILLION)

TABLE 46 AMERICAS RADIOPHARMACEUTICAL MARKET FOR PET RADIOPHARMACEUTICALS, BY TYPE, 2014-2023 (USD MILLION)

TABLE 47 AMERICAS RADIOPHARMACEUTICAL MARKET FOR THERAPEUTIC, BY TYPE, 2014-2023 (USD MILLION)

TABLE 48 AMERICAS RADIOPHARMACEUTICAL MARKET FOR BETA EMITTERS, BY TYPE, 2014-2023 (USD MILLION)

TABLE 49 AMERICAS RADIOPHARMACEUTICAL MARKET FOR BRACHYTHERAPY, BY TYPE, 2014-2023 (USD MILLION)

TABLE 50 AMERICAS RADIOPHARMACEUTICALS MARKET, BY TYPE OF TEST, 2014-2023 (USD MILLION)

TABLE 51 AMERICAS RADIOPHARMACEUTICALS MARKET FOR BONE SCAN, BY TYPE, 2014-2023 (USD MILLION)

TABLE 52 AMERICAS RADIOPHARMACEUTICALS MARKET FOR MYOCARDIAL PERFUSION SCAN, BY TYPE, 2014-2023 (USD MILLION)

TABLE 53 AMERICAS RADIOPHARMACEUTICALS MARKET FOR LUNG SCAN, BY TYPE, 2014-2023 (USD MILLION)

TABLE 54 AMERICAS RADIOPHARMACEUTICALS MARKET FOR WHITE BLOOD CELL SCAN, BY TYPE, 2014-2023 (USD MILLION)

TABLE 55 AMERICAS RADIOPHARMACEUTICAL MARKET, BY APPLICATION, 2014-2023 (USD MILLION)

TABLE 56 AMERICAS RADIOPHARMACEUTICAL MARKET FOR ONCOLOGY, BY TYPE, 2014-2023 (USD MILLION)

TABLE 57 AMERICAS RADIOPHARMACEUTICAL MARKET FOR CARDIOLOGY, BY TYPE, 2014-2023 (USD MILLION)

TABLE 58 AMERICAS RADIOPHARMACEUTICAL MARKET FOR NEUROLOGY, BY TYPE, 2014-2023 (USD MILLION)

TABLE 59 AMERICAS RADIOPHARMACEUTICAL MARKET FOR UROLOGY, BY TYPE, 2014-2023 (USD MILLION)

TABLE 60 AMERICAS RADIOPHARMACEUTICAL MARKET, BY ROUTE OF ADMINISTRATION, 2014-2023 (USD MILLION)

TABLE 61 AMERICAS RADIOPHARMACEUTICAL MARKET, BY END-USER, 2014-2023 (USD MILLION)

TABLE 62 U.S. RADIOPHARMACEUTICAL MARKET, BY TYPE, 2014-2023 (USD MILLION)

TABLE 63 U.S. RADIOPHARMACEUTICAL MARKET FOR DIAGNOSTIC, BY TYPE, 2014-2023 (USD MILLION)

TABLE 64 U.S. RADIOPHARMACEUTICAL MARKET FOR Z, 2014-2023 (USD MILLION)

TABLE 65 U.S. RADIOPHARMACEUTICAL MARKET FOR PET RADIOPHARMACEUTICALS, BY TYPE, 2014-2023 (USD MILLION)

TABLE 66 U.S. RADIOPHARMACEUTICAL MARKET FOR THERAPEUTIC, BY TYPE, 2014-2023 (USD MILLION)

TABLE 67 U.S. RADIOPHARMACEUTICAL MARKET FOR BETA EMITTERS, BY TYPE, 2014-2023 (USD MILLION)

TABLE 68 U.S. RADIOPHARMACEUTICAL MARKET FOR BRACHYTHERAPY, BY TYPE, 2014-2023 (USD MILLION)

TABLE 69 U.S. RADIOPHARMACEUTICALS MARKET, BY TYPE OF TEST, 2014-2023 (USD MILLION)

TABLE 70 U.S. RADIOPHARMACEUTICALS MARKET FOR BONE SCAN, BY TYPE, 2014-2023 (USD MILLION)

TABLE 71 U.S. RADIOPHARMACEUTICALS MARKET FOR MYOCARDIAL PERFUSION SCAN, BY TYPE, 2014-2023 (USD MILLION)

TABLE 72 U.S. RADIOPHARMACEUTICALS MARKET FOR LUNG SCAN, BY TYPE, 2014-2023 (USD MILLION)

TABLE 73 U.S. RADIOPHARMACEUTICALS MARKET FOR WHITE BLOOD CELL SCAN, BY TYPE, 2014-2023 (USD MILLION)

TABLE 74 U.S. RADIOPHARMACEUTICAL MARKET, BY APPLICATION, 2014-2023 (USD MILLION)

TABLE 75 U.S. RADIOPHARMACEUTICAL MARKET FOR ONCOLOGY, BY TYPE, 2014-2023 (USD MILLION)

TABLE 76 U.S. RADIOPHARMACEUTICAL MARKET FOR CARDIOLOGY, BY TYPE, 2014-2023 (USD MILLION)

TABLE 77 U.S. RADIOPHARMACEUTICAL MARKET FOR NEUROLOGY, BY TYPE, 2014-2023 (USD MILLION)

TABLE 78 U.S. RADIOPHARMACEUTICAL MARKET FOR UROLOGY, BY TYPE, 2014-2023 (USD MILLION)

TABLE 79 U.S. RADIOPHARMACEUTICAL MARKET, BY ROUTE OF ADMINISTRATION, 2014-2023 (USD MILLION)

TABLE 80 U.S. RADIOPHARMACEUTICAL MARKET, BY END-USER, 2014-2023 (USD MILLION)

TABLE 81 CANADA RADIOPHARMACEUTICAL MARKET, BY TYPE, 2014-2023 (USD MILLION)

TABLE 82 CANADA RADIOPHARMACEUTICAL MARKET FOR DIAGNOSTIC, BY TYPE, 2014-2023 (USD MILLION)

TABLE 83 CANADA RADIOPHARMACEUTICAL MARKET FOR SPECT RADIOPHARMACEUTICALS, BY TYPE, 2014-2023 (USD MILLION)

TABLE 84 CANADA RADIOPHARMACEUTICAL MARKET FOR PET RADIOPHARMACEUTICALS, BY TYPE, 2014-2023 (USD MILLION)

TABLE 85 CANADA RADIOPHARMACEUTICAL MARKET FOR THERAPEUTIC, BY TYPE, 2014-2023 (USD MILLION)

TABLE 86 CANADA RADIOPHARMACEUTICAL MARKET FOR BETA EMITTERS, BY TYPE, 2014-2023 (USD MILLION) 91

TABLE 87 CANADA RADIOPHARMACEUTICAL MARKET FOR BRACHYTHERAPY, BY TYPE, 2014-2023 (USD MILLION) 91

TABLE 88 CANADA RADIOPHARMACEUTICALS MARKET, BY TYPE OF TEST, 2014-2023 (USD MILLION) 92

TABLE 89 CANADA RADIOPHARMACEUTICALS MARKET FOR BONE SCAN, BY TYPE, 2014-2023 (USD MILLION) 92

TABLE 90 CANADA RADIOPHARMACEUTICALS MARKET FOR MYOCARDIAL PERFUSION SCAN, BY TYPE, 2014-2023 (USD MILLION) 93

TABLE 91 CANADA RADIOPHARMACEUTICALS MARKET FOR LUNG SCAN, BY TYPE, 2014-2023 (USD MILLION) 93

TABLE 92 CANADA RADIOPHARMACEUTICALS MARKET FOR WHITE BLOOD CELL SCAN, BY TYPE, 2014-2023 (USD MILLION) 93

TABLE 93 CANADA RADIOPHARMACEUTICAL MARKET, BY APPLICATION, 2014-2023 (USD MILLION) 94

TABLE 94 CANADA RADIOPHARMACEUTICAL MARKET FOR ONCOLOGY, BY TYPE, 2014-2023 (USD MILLION) 94

TABLE 95 CANADA RADIOPHARMACEUTICAL MARKET FOR CARDIOLOGY, BY TYPE, 2014-2023 (USD MILLION) 94

TABLE 96 CANADA RADIOPHARMACEUTICAL MARKET FOR NEUROLOGY, BY TYPE, 2014-2023 (USD MILLION) 95

TABLE 97 CANADA RADIOPHARMACEUTICAL MARKET FOR UROLOGY, BY TYPE, 2014-2023 (USD MILLION) 95

TABLE 98 CANADA RADIOPHARMACEUTICAL MARKET, BY ROUTE OF ADMINISTRATION, 2014-2023 (USD MILLION) 95

TABLE 99 CANADA RADIOPHARMACEUTICAL MARKET, BY END-USER, 2014-2023 (USD MILLION) 96

TABLE 100 SOUTH AMERICA RADIOPHARMACEUTICAL MARKET, BY TYPE, 2014-2023 (USD MILLION) 96

TABLE 101 SOUTH AMERICA RADIOPHARMACEUTICAL MARKET FOR DIAGNOSTIC, BY TYPE, 2014-2023 (USD MILLION) 96

TABLE 102 SOUTH AMERICA RADIOPHARMACEUTICAL MARKET FOR SPECT RADIOPHARMACEUTICAL, BY TYPE,

2014-2023 (USD MILLION) 97

TABLE 103 SOUTH AMERICA RADIOPHARMACEUTICAL MARKET FOR PET RADIOPHARMACEUTICALS, BY TYPE,

2014-2023 (USD MILLION) 97

TABLE 104 SOUTH AMERICA RADIOPHARMACEUTICAL MARKET FOR THERAPEUTIC, BY TYPE, 2014-2023 (USD MILLION) 97

TABLE 105 SOUTH AMERICA RADIOPHARMACEUTICAL MARKET FOR BETA EMITTERS, BY TYPE, 2014-2023 (USD MILLION) 98

TABLE 106 SOUTH AMERICA RADIOPHARMACEUTICAL MARKET FOR BRACHYTHERAPY, BY TYPE, 2014-2023 (USD MILLION) 98

TABLE 107 SOUTH AMERICA RADIOPHARMACEUTICALS MARKET, BY TYPE OF TEST, 2014-2023 (USD MILLION) 99

TABLE 108 SOUTH AMERICA RADIOPHARMACEUTICALS MARKET FOR BONE SCAN, BY TYPE, 2014-2023 (USD MILLION) 99

TABLE 109 SOUTH AMERICA RADIOPHARMACEUTICALS MARKET FOR MYOCARDIAL PERFUSION SCAN, BY TYPE,

2014-2023 (USD MILLION) 100

TABLE 110 SOUTH AMERICA RADIOPHARMACEUTICALS MARKET FOR LUNG SCAN, BY TYPE, 2014-2023 (USD MILLION) 100

TABLE 111 SOUTH AMERICA RADIOPHARMACEUTICALS MARKET FOR WHITE BLOOD CELL SCAN, BY TYPE, 2014-2023 (USD MILLION) 100

TABLE 112 SOUTH AMERICA RADIOPHARMACEUTICAL MARKET, BY APPLICATION, 2014-2023 (USD MILLION) 101

TABLE 113 SOUTH AMERICA RADIOPHARMACEUTICAL MARKET FOR ONCOLOGY, BY TYPE, 2014-2023 (USD MILLION) 101

TABLE 114 SOUTH AMERICA RADIOPHARMACEUTICAL MARKET FOR CARDIOLOGY, BY TYPE, 2014-2023 (USD MILLION) 101

TABLE 115 SOUTH AMERICA RADIOPHARMACEUTICAL MARKET FOR NEUROLOGY, BY TYPE, 2014-2023 (USD MILLION) 102

TABLE 116 SOUTH AMERICA RADIOPHARMACEUTICAL MARKET FOR UROLOGY, BY TYPE, 2014-2023 (USD MILLION) 102

TABLE 117 SOUTH AMERICA RADIOPHARMACEUTICAL MARKET, BY ROUTE OF ADMINISTRATION, 2014-2023 (USD MILLION) 102

TABLE 118 SOUTH AMERICA RADIOPHARMACEUTICAL MARKET, BY END-USER, 2014-2023 (USD MILLION) 103

TABLE 119 EUROPE RADIOPHARMACEUTICAL MARKET, BY COUNTRY, 2014-2023 (USD MILLION) 103

TABLE 120 EUROPE RADIOPHARMACEUTICAL MARKET, BY TYPE, 2014-2023 (USD MILLION) 104

TABLE 121 EUROPE RADIOPHARMACEUTICAL MARKET FOR DIAGNOSTIC, BY TYPE, 2014-2023 (USD MILLION) 104

TABLE 122 EUROPE RADIOPHARMACEUTICAL MARKET FOR SPECT RADIOPHARMACEUTICALS, BY TYPE, 2014-2023 (USD MILLION) 105

TABLE 123 EUROPE RADIOPHARMACEUTICAL MARKET FOR PET RADIOPHARMACEUTICALS, BY TYPE, 2014-2023 (USD MILLION) 105

TABLE 124 EUROPE RADIOPHARMACEUTICAL MARKET FOR THERAPEUTIC, BY TYPE, 2014-2023 (USD MILLION) 105

TABLE 125 EUROPE RADIOPHARMACEUTICAL MARKET FOR BETA EMITTERS, BY TYPE, 2014-2023 (USD MILLION) 106

TABLE 126 EUROPE RADIOPHARMACEUTICAL MARKET FOR BRACHYTHERAPY, BY TYPE, 2014-2023 (USD MILLION) 106

TABLE 127 EUROPE RADIOPHARMACEUTICALS MARKET, BY TYPE OF TEST, 2014-2023 (USD MILLION) 107

TABLE 128 EUROPE RADIOPHARMACEUTICALS MARKET FOR BONE SCAN, BY TYPE, 2014-2023 (USD MILLION) 107

TABLE 129 EUROPE RADIOPHARMACEUTICALS MARKET FOR MYOCARDIAL PERFUSION SCAN, BY TYPE, 2014-2023 (USD MILLION) 108

TABLE 130 EUROPE RADIOPHARMACEUTICALS MARKET FOR LUNG SCAN, BY TYPE, 2014-2023 (USD MILLION) 108

TABLE 131 EUROPE RADIOPHARMACEUTICALS MARKET FOR WHITE BLOOD CELL SCAN, BY TYPE, 2014-2023 (USD MILLION) 108

TABLE 132 EUROPE RADIOPHARMACEUTICAL MARKET, BY APPLICATION, 2014-2023 (USD MILLION) 109

TABLE 133 EUROPE RADIOPHARMACEUTICAL MARKET FOR ONCOLOGY, BY TYPE, 2014-2023 (USD MILLION) 109

TABLE 134 EUROPE RADIOPHARMACEUTICAL MARKET FOR CARDIOLOGY, BY TYPE, 2014-2023 (USD MILLION) 109

TABLE 135 EUROPE RADIOPHARMACEUTICAL MARKET FOR NEUROLOGY, BY TYPE, 2014-2023 (USD MILLION) 110

TABLE 136 EUROPE RADIOPHARMACEUTICAL MARKET FOR UROLOGY, BY TYPE, 2014-2023 (USD MILLION) 110

TABLE 137 EUROPE RADIOPHARMACEUTICAL MARKET, BY ROUTE OF ADMINISTRATION, 2014-2023 (USD MILLION) 110

TABLE 138 EUROPE RADIOPHARMACEUTICAL MARKET, BY END-USER, 2014-2023 (USD MILLION) 111

TABLE 139 GERMANY RADIOPHARMACEUTICAL MARKET, BY TYPE, 2014-2023 (USD MILLION) 111

TABLE 140 GERMANY RADIOPHARMACEUTICAL MARKET FOR DIAGNOSTIC, BY TYPE, 2014-2023 (USD MILLION) 111

TABLE 141 GERMANY RADIOPHARMACEUTICAL MARKET FOR SPECT RADIOPHARMACEUTICALS, BY TYPE, 2014-2023 (USD MILLION) 112

TABLE 142 GERMANY RADIOPHARMACEUTICAL MARKET FOR PET RADIOPHARMACEUTICALS, BY TYPE, 2014-2023 (USD MILLION) 112

TABLE 143 GERMANY RADIOPHARMACEUTICAL MARKET FOR THERAPEUTIC, BY TYPE, 2014-2023 (USD MILLION) 112

TABLE 144 GERMANY RADIOPHARMACEUTICAL MARKET FOR BETA EMITTERS, BY TYPE, 2014-2023 (USD MILLION) 113

TABLE 145 GERMANY RADIOPHARMACEUTICAL MARKET FOR BRACHYTHERAPY, BY TYPE, 2014-2023 (USD MILLION) 113

TABLE 146 GERMANY RADIOPHARMACEUTICALS MARKET, BY TYPE OF TEST, 2014-2023 (USD MILLION) 114

TABLE 147 GERMANY RADIOPHARMACEUTICALS MARKET FOR BONE SCAN, BY TYPE, 2014-2023 (USD MILLION) 114

TABLE 148 GERMANY RADIOPHARMACEUTICALS MARKET FOR MYOCARDIAL PERFUSION SCAN, BY TYPE, 2014-2023 (USD MILLION) 115

TABLE 149 GERMANY RADIOPHARMACEUTICALS MARKET FOR LUNG SCAN, BY TYPE, 2014-2023 (USD MILLION) 115

TABLE 150 GERMANY RADIOPHARMACEUTICALS MARKET FOR WHITE BLOOD CELL SCAN, BY TYPE, 2014-2023 (USD MILLION) 115

TABLE 151 GERMANY RADIOPHARMACEUTICAL MARKET, BY APPLICATION, 2014-2023 (USD MILLION) 116

TABLE 152 GERMANY RADIOPHARMACEUTICAL MARKET FOR ONCOLOGY, BY TYPE, 2014-2023 (USD MILLION) 116

TABLE 153 GERMANY RADIOPHARMACEUTICAL MARKET FOR CARDIOLOGY, BY TYPE, 2014-2023 (USD MILLION) 116

TABLE 154 GERMANY RADIOPHARMACEUTICAL MARKET FOR NEUROLOGY, BY TYPE, 2014-2023 (USD MILLION) 117

TABLE 155 GERMANY RADIOPHARMACEUTICAL MARKET FOR UROLOGY, BY TYPE, 2014-2023 (USD MILLION) 117

TABLE 156 GERMANY RADIOPHARMACEUTICAL MARKET, BY ROUTE OF ADMINISTRATION, 2014-2023 (USD MILLION) 117

TABLE 157 GERMANY RADIOPHARMACEUTICAL MARKET, BY END-USER, 2014-2023 (USD MILLION) 118

TABLE 158 FRANCE RADIOPHARMACEUTICAL MARKET, BY TYPE, 2014-2023 (USD MILLION) 118

TABLE 159 FRANCE RADIOPHARMACEUTICAL MARKET FOR DIAGNOSTIC, BY TYPE, 2014-2023 (USD MILLION) 118

TABLE 160 FRANCE RADIOPHARMACEUTICAL MARKET FOR SPECT RADIOPHARMACEUTICALS, BY TYPE, 2014-2023 (USD MILLION) 119

TABLE 161 FRANCE RADIOPHARMACEUTICAL MARKET FOR PET RADIOPHARMACEUTICALS, BY TYPE, 2014-2023 (USD MILLION) 119

TABLE 162 FRANCE RADIOPHARMACEUTICAL MARKET FOR THERAPEUTIC, BY TYPE, 2014-2023 (USD MILLION) 119

TABLE 163 FRANCE RADIOPHARMACEUTICAL MARKET FOR BETA EMITTERS, BY TYPE, 2014-2023 (USD MILLION) 120

TABLE 164 FRANCE RADIOPHARMACEUTICAL MARKET FOR BRACHYTHERAPY, BY TYPE, 2014-2023 (USD MILLION) 120

TABLE 165 FRANCE RADIOPHARMACEUTICALS MARKET, BY TYPE OF TEST, 2014-2023 (USD MILLION) 121

TABLE 166 FRANCE RADIOPHARMACEUTICALS MARKET FOR BONE SCAN, BY TYPE, 2014-2023 (USD MILLION) 121

TABLE 167 FRANCE RADIOPHARMACEUTICALS MARKET FOR MYOCARDIAL PERFUSION SCAN, BY TYPE, 2014-2023 (USD MILLION) 122

TABLE 168 FRANCE RADIOPHARMACEUTICALS MARKET FOR LUNG SCAN, BY TYPE, 2014-2023 (USD MILLION) 122

TABLE 169 FRANCE RADIOPHARMACEUTICALS MARKET FOR WHITE BLOOD CELL SCAN, BY TYPE, 2014-2023 (USD MILLION) 122

TABLE 170 FRANCE RADIOPHARMACEUTICAL MARKET, BY APPLICATION, 2014-2023 (USD MILLION) 123

TABLE 171 FRANCE RADIOPHARMACEUTICAL MARKET FOR ONCOLOGY, BY TYPE, 2014-2023 (USD MILLION) 123

TABLE 172 FRANCE RADIOPHARMACEUTICAL MARKET FOR CARDIOLOGY, BY TYPE, 2014-2023 (USD MILLION) 123

TABLE 173 FRANCE RADIOPHARMACEUTICAL MARKET FOR NEUROLOGY, BY TYPE, 2014-2023 (USD MILLION) 124

TABLE 174 FRANCE RADIOPHARMACEUTICAL MARKET FOR UROLOGY, BY TYPE, 2014-2023 (USD MILLION) 124

TABLE 175 FRANCE RADIOPHARMACEUTICAL MARKET, BY ROUTE OF ADMINISTRATION, 2014-2023 (USD MILLION) 124

TABLE 176 FRANCE RADIOPHARMACEUTICAL MARKET, BY END-USER, 2014-2023 (USD MILLION) 125

TABLE 177 U.K. RADIOPHARMACEUTICAL MARKET, BY TYPE, 2014-2023 (USD MILLION) 125

TABLE 178 U.K. RADIOPHARMACEUTICAL MARKET FOR DIAGNOSTIC, BY TYPE, 2014-2023 (USD MILLION) 125

TABLE 179 U.K. RADIOPHARMACEUTICAL MARKET FOR SPECT RADIOPHARMACEUTICALS, BY TYPE, 2014-2023 (USD MILLION) 126

TABLE 180 U.K. RADIOPHARMACEUTICAL MARKET FOR PET RADIOPHARMACEUTICALS, BY TYPE, 2014-2023 (USD MILLION) 126

TABLE 181 U.K. RADIOPHARMACEUTICAL MARKET FOR THERAPEUTIC, BY TYPE, 2014-2023 (USD MILLION) 126

TABLE 182 U.K. RADIOPHARMACEUTICAL MARKET FOR BETA EMITTERS, BY TYPE, 2014-2023 (USD MILLION) 127

TABLE 183 U.K. RADIOPHARMACEUTICAL MARKET FOR BRACHYTHERAPY, BY TYPE, 2014-2023 (USD MILLION) 127

TABLE 184 U.K. RADIOPHARMACEUTICALS MARKET, BY TYPE OF TEST, 2014-2023 (USD MILLION) 128

TABLE 185 U.K. RADIOPHARMACEUTICALS MARKET FOR BONE SCAN, BY TYPE, 2014-2023 (USD MILLION) 128

TABLE 186 U.K. RADIOPHARMACEUTICALS MARKET FOR MYOCARDIAL PERFUSION SCAN, BY TYPE, 2014-2023 (USD MILLION) 129

TABLE 187 U.K. RADIOPHARMACEUTICALS MARKET FOR LUNG SCAN, BY TYPE, 2014-2023 (USD MILLION) 129

TABLE 188 U.K. RADIOPHARMACEUTICALS MARKET FOR WHITE BLOOD CELL SCAN, BY TYPE, 2014-2023 (USD MILLION) 129

TABLE 189 U.K. RADIOPHARMACEUTICAL MARKET, BY APPLICATION, 2014-2023 (USD MILLION) 130

TABLE 190 U.K. RADIOPHARMACEUTICAL MARKET FOR ONCOLOGY, BY TYPE, 2014-2023 (USD MILLION) 130

TABLE 191 U.K. RADIOPHARMACEUTICAL MARKET FOR CARDIOLOGY, BY TYPE, 2014-2023 (USD MILLION) 130

TABLE 192 U.K. RADIOPHARMACEUTICAL MARKET FOR NEUROLOGY, BY TYPE, 2014-2023 (USD MILLION) 131

TABLE 193 U.K. RADIOPHARMACEUTICAL MARKET FOR UROLOGY, BY TYPE, 2014-2023 (USD MILLION) 131

TABLE 194 U.K. RADIOPHARMACEUTICAL MARKET, BY ROUTE OF ADMINISTRATION, 2014-2023 (USD MILLION) 131

TABLE 195 U.K. RADIOPHARMACEUTICAL MARKET, BY END-USER, 2014-2023 (USD MILLION) 132

TABLE 196 ITALY RADIOPHARMACEUTICAL MARKET, BY TYPE, 2014-2023 (USD MILLION) 132

TABLE 197 ITALY RADIOPHARMACEUTICAL MARKET FOR DIAGNOSTIC, BY TYPE, 2014-2023 (USD MILLION) 132

TABLE 198 ITALY RADIOPHARMACEUTICAL MARKET FOR SPECT RADIOPHARMACEUTICALS, BY TYPE, 2014-2023 (USD MILLION) 133

TABLE 199 ITALY RADIOPHARMACEUTICAL MARKET FOR PET RADIOPHARMACEUTICALS, BY TYPE, 2014-2023 (USD MILLION) 133

TABLE 200 ITALY RADIOPHARMACEUTICAL MARKET FOR THERAPEUTIC, BY TYPE, 2014-2023 (USD MILLION) 133

TABLE 201 ITALY RADIOPHARMACEUTICAL MARKET FOR BETA EMITTERS, BY TYPE, 2014-2023 (USD MILLION) 134

TABLE 202 ITALY RADIOPHARMACEUTICAL MARKET FOR BRACHYTHERAPY, BY TYPE, 2014-2023 (USD MILLION) 134

TABLE 203 ITALY RADIOPHARMACEUTICALS MARKET, BY TYPE OF TEST, 2014-2023 (USD MILLION) 135

TABLE 204 ITALY RADIOPHARMACEUTICALS MARKET FOR BONE SCAN, BY TYPE, 2014-2023 (USD MILLION) 135

TABLE 205 ITALY RADIOPHARMACEUTICALS MARKET FOR MYOCARDIAL PERFUSION SCAN, BY TYPE, 2014-2023 (USD MILLION) 136

TABLE 206 ITALY RADIOPHARMACEUTICALS MARKET FOR LUNG SCAN, BY TYPE, 2014-2023 (USD MILLION) 136

TABLE 207 ITALY RADIOPHARMACEUTICALS MARKET FOR WHITE BLOOD CELL SCAN, BY TYPE, 2014-2023 (USD MILLION) 136

TABLE 208 ITALY RADIOPHARMACEUTICAL MARKET, BY APPLICATION, 2014-2023 (USD MILLION) 137

TABLE 209 ITALY RADIOPHARMACEUTICAL MARKET FOR ONCOLOGY, BY TYPE, 2014-2023 (USD MILLION) 137

TABLE 210 ITALY RADIOPHARMACEUTICAL MARKET FOR CARDIOLOGY, BY TYPE, 2014-2023 (USD MILLION) 137

TABLE 211 ITALY RADIOPHARMACEUTICAL MARKET FOR NEUROLOGY, BY TYPE, 2014-2023 (USD MILLION) 138

TABLE 212 ITALY RADIOPHARMACEUTICAL MARKET FOR UROLOGY, BY TYPE, 2014-2023 (USD MILLION) 138

TABLE 213 ITALY RADIOPHARMACEUTICAL MARKET, BY ROUTE OF ADMINISTRATION, 2014-2023 (USD MILLION) 138

TABLE 214 ITALY RADIOPHARMACEUTICAL MARKET, BY END-USER, 2014-2023 (USD MILLION) 139

TABLE 215 SPAIN RADIOPHARMACEUTICAL MARKET, BY TYPE, 2014-2023 (USD MILLION) 139

TABLE 216 SPAIN RADIOPHARMACEUTICAL MARKET FOR DIAGNOSTIC, BY TYPE, 2014-2023 (USD MILLION) 139

TABLE 217 SPAIN RADIOPHARMACEUTICAL MARKET FOR SPECT RADIOPHARMACEUTICALS, BY TYPE, 2014-2023 (USD MILLION) 140

TABLE 218 SPAIN RADIOPHARMACEUTICAL MARKET FOR PET RADIOPHARMACEUTICALS, BY TYPE, 2014-2023 (USD MILLION) 140

TABLE 219 SPAIN RADIOPHARMACEUTICAL MARKET FOR THERAPEUTIC, BY TYPE, 2014-2023 (USD MILLION) 140

TABLE 220 SPAIN RADIOPHARMACEUTICAL MARKET FOR BETA EMITTERS, BY TYPE, 2014-2023 (USD MILLION) 141

TABLE 221 SPAIN RADIOPHARMACEUTICAL MARKET FOR BRACHYTHERAPY, BY TYPE, 2014-2023 (USD MILLION) 141

TABLE 222 SPAIN RADIOPHARMACEUTICALS MARKET, BY TYPE OF TEST, 2014-2023 (USD MILLION) 142

TABLE 223 SPAIN RADIOPHARMACEUTICALS MARKET FOR BONE SCAN, BY TYPE, 2014-2023 (USD MILLION) 142

TABLE 224 SPAIN RADIOPHARMACEUTICALS MARKET FOR MYOCARDIAL PERFUSION SCAN, BY TYPE, 2014-2023 (USD MILLION) 143

TABLE 225 SPAIN RADIOPHARMACEUTICALS MARKET FOR LUNG SCAN, BY TYPE, 2014-2023 (USD MILLION) 143

TABLE 226 SPAIN RADIOPHARMACEUTICALS MARKET FOR WHITE BLOOD CELL SCAN, BY TYPE, 2014-2023 (USD MILLION) 143

TABLE 227 SPAIN RADIOPHARMACEUTICAL MARKET, BY APPLICATION, 2014-2023 (USD MILLION) 144

TABLE 228 SPAIN RADIOPHARMACEUTICAL MARKET FOR ONCOLOGY, BY TYPE, 2014-2023 (USD MILLION) 144

TABLE 229 SPAIN RADIOPHARMACEUTICAL MARKET FOR CARDIOLOGY, BY TYPE, 2014-2023 (USD MILLION) 144

TABLE 230 SPAIN RADIOPHARMACEUTICAL MARKET FOR NEUROLOGY, BY TYPE, 2014-2023 (USD MILLION) 145

TABLE 231 SPAIN RADIOPHARMACEUTICAL MARKET FOR UROLOGY, BY TYPE, 2014-2023 (USD MILLION) 145

TABLE 232 SPAIN RADIOPHARMACEUTICAL MARKET, BY ROUTE OF ADMINISTRATION, 2014-2023 (USD MILLION) 145

TABLE 233 SPAIN RADIOPHARMACEUTICAL MARKET, BY END-USER, 2014-2023 (USD MILLION) 146

TABLE 234 REST OF WESTERN EUROPE RADIOPHARMACEUTICAL MARKET, BY TYPE, 2014-2023 (USD MILLION) 146

TABLE 235 REST OF WESTERN EUROPE RADIOPHARMACEUTICAL MARKET FOR DIAGNOSTIC, BY TYPE, 2014-2023 (USD MILLION) 146

TABLE 236 REST OF WESTERN EUROPE RADIOPHARMACEUTICAL MARKET FOR SPECT RADIOPHARMACEUTICALS, BY TYPE,

2014-2023 (USD MILLION) 147

TABLE 237 REST OF WESTERN EUROPE RADIOPHARMACEUTICAL MARKET FOR PET RADIOPHARMACEUTICALS, BY TYPE,

2014-2023 (USD MILLION) 147

TABLE 238 REST OF WESTERN EUROPE RADIOPHARMACEUTICAL MARKET FOR THERAPEUTIC, BY TYPE, 2014-2023 (USD MILLION) 147

TABLE 239 REST OF WESTERN EUROPE RADIOPHARMACEUTICAL MARKET FOR BETA EMITTERS, BY TYPE, 2014-2023 (USD MILLION) 148

TABLE 240 REST OF WESTERN EUROPE RADIOPHARMACEUTICAL MARKET FOR BRACHYTHERAPY, BY TYPE, 2014-2023 (USD MILLION) 148

TABLE 241 REST OF WESTERN EUROPE RADIOPHARMACEUTICALS MARKET, BY TYPE OF TEST, 2014-2023 (USD MILLION) 149

TABLE 242 REST OF WESTERN EUROPE RADIOPHARMACEUTICALS MARKET FOR BONE SCAN, BY TYPE, 2014-2023 (USD MILLION) 149

TABLE 243 REST OF WESTERN EUROPE RADIOPHARMACEUTICALS MARKET FOR MYOCARDIAL PERFUSION SCAN, BY TYPE,

2014-2023 (USD MILLION) 150

TABLE 244 REST OF WESTERN EUROPE RADIOPHARMACEUTICALS MARKET FOR LUNG SCAN, BY TYPE, 2014-2023 (USD MILLION) 150

TABLE 245 REST OF WESTERN EUROPE RADIOPHARMACEUTICALS MARKET FOR WHITE BLOOD CELL SCAN, BY TYPE,

2014-2023 (USD MILLION) 150

Jubilant Life Sciences Ltd., Siemens AG,Sun Pharmaceutical Industries Ltd., Bayer AG, Cardinal Health Inc, Bayer AG, Cardinal Health Inc., General Electric Company, Lantheus Medical Imaging, Inc., Avid Radiopharmaceuticals, IBA Dosimetry


Related Products in vertical
red-whiteline

RECENT VIEWED REPORTS



Sign up for newsletter

Close
Apply For Job

  • Applicant Name
  • Job Function
  • Total Experience
  • Skills
  • Email ID
  • Notice Period
  • Current CTC & Expected CTC
  • Phone Number
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Your resume has been successfully received. HR will connect you within 14 days in case your resume gets shortlisted."
Close
Download Company Brochure

  • Name
  • Email
  • Company Name
  • Select Country*
  • Phone Number
  • Validation
  •   info-icon

    If validation code does not match, please refresh the page.

Close
Engage With Us

  • Name
  • Designation
  • Email
  • Phone No.
  • Company Name
  • Company URL
  • Select Country*
  • Requirements/ Comments
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Thanks for submitting the form. The concerned team will respond to your query in the next 8-12 hours"
Close

Compare

Expand

person